Global Poly (L-lactide-co-e-caprolactone) (PLCL) Market Growth 2024-2030

Publication ID:

LPI07243563

Publication Date:

July 16, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

Polylactic acid (PLA) has good biocompatibility and processing properties, but its slow degradation rate, brittle texture, and low mechanical strength limit its application. Polycaprolactone (PCL) has good biocompatibility, biodegradability and drug permeability, and has good toughness, processability and heat induced shape memory properties. However, PCL has low strength and poor hydrophilicity, which limits its application. By introducing CL segments into PLA through copolymerization modification, the crystallinity, biodegradability, and mechanical properties of the product can be adjusted, resulting in good flexibility and elasticity of the material. It can be widely used in fields such as biomaterials, 3D printing, and biodegradable biological products.
The global Poly (L-lactide-co-e-caprolactone) (PLCL) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧oly (L-lactide-co-e-caprolactone) (PLCL) Industry Forecast鈥� looks at past sales and reviews total world Poly (L-lactide-co-e-caprolactone) (PLCL) sales in 2023, providing a comprehensive analysis by region and market sector of projected Poly (L-lactide-co-e-caprolactone) (PLCL) sales for 2024 through 2030. With Poly (L-lactide-co-e-caprolactone) (PLCL) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poly (L-lactide-co-e-caprolactone) (PLCL) industry.
This Insight Report provides a comprehensive analysis of the global Poly (L-lactide-co-e-caprolactone) (PLCL) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poly (L-lactide-co-e-caprolactone) (PLCL) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Poly (L-lactide-co-e-caprolactone) (PLCL) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poly (L-lactide-co-e-caprolactone) (PLCL) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poly (L-lactide-co-e-caprolactone) (PLCL).
United States market for Poly (L-lactide-co-e-caprolactone) (PLCL) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Poly (L-lactide-co-e-caprolactone) (PLCL) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Poly (L-lactide-co-e-caprolactone) (PLCL) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Poly (L-lactide-co-e-caprolactone) (PLCL) players cover Evonik, eSUNMED, Suzhou Qihang, Narui Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Poly (L-lactide-co-e-caprolactone) (PLCL) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
LA:CL 30:70
LA:CL 50:50
Others
Segmentation by Application:
Tissue Engineering
Surgical Suture
Drug Delivery
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik
eSUNMED
Suzhou Qihang
Narui Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Poly (L-lactide-co-e-caprolactone) (PLCL) market?
What factors are driving Poly (L-lactide-co-e-caprolactone) (PLCL) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poly (L-lactide-co-e-caprolactone) (PLCL) market opportunities vary by end market size?
How does Poly (L-lactide-co-e-caprolactone) (PLCL) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Poly (L-lactide-co-e-caprolactone) (PLCL) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Poly (L-lactide-co-e-caprolactone) (PLCL) by Country/Region, 2019, 2023 & 2030
2.2 Poly (L-lactide-co-e-caprolactone) (PLCL) Segment by Type
2.2.1 LA:CL 30:70
2.2.2 LA:CL 50:50
2.2.3 Others
2.3 Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Type
2.3.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Market Share by Type (2019-2024)
2.3.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sale Price by Type (2019-2024)
2.4 Poly (L-lactide-co-e-caprolactone) (PLCL) Segment by Application
2.4.1 Tissue Engineering
2.4.2 Surgical Suture
2.4.3 Drug Delivery
2.4.4 Others
2.5 Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Application
2.5.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sale Market Share by Application (2019-2024)
2.5.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Breakdown Data by Company
3.1.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Sales by Company (2019-2024)
3.1.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Market Share by Company (2019-2024)
3.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Revenue by Company (2019-2024)
3.2.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue by Company (2019-2024)
3.2.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue Market Share by Company (2019-2024)
3.3 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Sale Price by Company
3.4 Key Manufacturers Poly (L-lactide-co-e-caprolactone) (PLCL) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Poly (L-lactide-co-e-caprolactone) (PLCL) Product Location Distribution
3.4.2 Players Poly (L-lactide-co-e-caprolactone) (PLCL) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Poly (L-lactide-co-e-caprolactone) (PLCL) by Geographic Region
4.1 World Historic Poly (L-lactide-co-e-caprolactone) (PLCL) Market Size by Geographic Region (2019-2024)
4.1.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Poly (L-lactide-co-e-caprolactone) (PLCL) Market Size by Country/Region (2019-2024)
4.2.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Growth
4.4 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Growth
4.5 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Growth
4.6 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) Sales Growth
5 Americas
5.1 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Country
5.1.1 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Country (2019-2024)
5.1.2 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue by Country (2019-2024)
5.2 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Type (2019-2024)
5.3 Americas Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Region
6.1.1 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Region (2019-2024)
6.1.2 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue by Region (2019-2024)
6.2 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Type (2019-2024)
6.3 APAC Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) by Country
7.1.1 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Country (2019-2024)
7.1.2 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue by Country (2019-2024)
7.2 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Type (2019-2024)
7.3 Europe Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) by Country
8.1.1 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) Revenue by Country (2019-2024)
8.2 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Type (2019-2024)
8.3 Middle East & Africa Poly (L-lactide-co-e-caprolactone) (PLCL) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Poly (L-lactide-co-e-caprolactone) (PLCL)
10.3 Manufacturing Process Analysis of Poly (L-lactide-co-e-caprolactone) (PLCL)
10.4 Industry Chain Structure of Poly (L-lactide-co-e-caprolactone) (PLCL)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Poly (L-lactide-co-e-caprolactone) (PLCL) Distributors
11.3 Poly (L-lactide-co-e-caprolactone) (PLCL) Customer
12 World Forecast Review for Poly (L-lactide-co-e-caprolactone) (PLCL) by Geographic Region
12.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Market Size Forecast by Region
12.1.1 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Forecast by Region (2025-2030)
12.1.2 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Forecast by Type (2025-2030)
12.7 Global Poly (L-lactide-co-e-caprolactone) (PLCL) Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Evonik
13.1.1 Evonik Company Information
13.1.2 Evonik Poly (L-lactide-co-e-caprolactone) (PLCL) Product Portfolios and Specifications
13.1.3 Evonik Poly (L-lactide-co-e-caprolactone) (PLCL) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Evonik Main Business Overview
13.1.5 Evonik Latest Developments
13.2 eSUNMED
13.2.1 eSUNMED Company Information
13.2.2 eSUNMED Poly (L-lactide-co-e-caprolactone) (PLCL) Product Portfolios and Specifications
13.2.3 eSUNMED Poly (L-lactide-co-e-caprolactone) (PLCL) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 eSUNMED Main Business Overview
13.2.5 eSUNMED Latest Developments
13.3 Suzhou Qihang
13.3.1 Suzhou Qihang Company Information
13.3.2 Suzhou Qihang Poly (L-lactide-co-e-caprolactone) (PLCL) Product Portfolios and Specifications
13.3.3 Suzhou Qihang Poly (L-lactide-co-e-caprolactone) (PLCL) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Suzhou Qihang Main Business Overview
13.3.5 Suzhou Qihang Latest Developments
13.4 Narui Bio
13.4.1 Narui Bio Company Information
13.4.2 Narui Bio Poly (L-lactide-co-e-caprolactone) (PLCL) Product Portfolios and Specifications
13.4.3 Narui Bio Poly (L-lactide-co-e-caprolactone) (PLCL) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Narui Bio Main Business Overview
13.4.5 Narui Bio Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂